Advocacy intelligence hub — real-time data for patient organizations
Agios Pharmaceuticals, Inc. — PHASE3
Agios Pharmaceuticals, Inc. — PHASE3
Massachusetts General Hospital
Agios Pharmaceuticals, Inc.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs